aspirin has been researched along with Urinary Bladder Neoplasms in 50 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the impact of fibrin clot inhibitor (FCI) use on oncological outcomes in a large contemporary cohort of patients with non-muscle-invasive bladder cancer (NMIBC) treated with adequate bacille Calmette-Guérin (BCG)." | 8.12 | Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Guérin? ( Bree, KK; Dinney, CP; Hensley, PJ; Kamat, AM; Lobo, N; Navai, N; Nogueras-Gonzalez, GM, 2022) |
| "The analysis of relevant databases will improve our mechanistic understanding of the role of aspirin in bladder cancer." | 8.12 | The targets of aspirin in bladder cancer: bioinformatics analysis. ( Gao, Y; Li, X; Liu, S; Tai, Y; Wang, X; Yin, J; Zhang, D; Zhang, DF; Zhang, H; Zhang, K, 2022) |
| "This study aimed to evaluate the behavior of non-muscle-invasive bladder cancer (NMIBC) in patients submitted to transurethral bladder resection (TURB) comparing subjects in chronic therapy with aspirin, statins, or both drugs to untreated ones." | 7.81 | Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection. ( Al Salhi, Y; Carbone, A; Costantini, E; de Nunzio, C; Fuschi, A; Palleschi, G; Pastore, A; Petrozza, V; Silvestri, L; Zucchi, A, 2015) |
| "To evaluate the recurrence-free survival (RFS) rate of patients taking cardioprotective aspirin after intravesical bacille Calmette-Guérin (BCG) for high-grade noninvasive urothelial carcinoma of the bladder, as preventing the recurrence of superficial bladder cancer might decrease patient morbidity and mortality from this disease, and nonsteroidal anti-inflammatory agents (NSAIDs) have shown promise in preclinical prevention through inhibition of the prostaglandin pathway and other mechanisms." | 7.75 | Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guérin. ( Bruskewitz, RC; Gee, JR; Hedican, SP; Jarrard, DF; Leverson, GE; Messing, EM; Moon, TD; Nakada, SY, 2009) |
| "Naproxen, which has an excellent cardiovascular profile, or epidermal growth factor receptor inhibitors may be effective in an adjuvant setting." | 5.36 | Screening agents for preventive efficacy in a bladder cancer model: study design, end points, and gefitinib and naproxen efficacy. ( Grubbs, CJ; Juliana, MM; Lubet, RA; Steele, VE, 2010) |
| "The current results suggest that continued use of anti-aggregant monotherapy does not increase the risk of overall bleeding or reintervention for patients undergoing transurethral resection of bladder neoplasms and that suspending aspirin before such a procedure is therefore unnecessary." | 5.19 | Risks and complications of transurethral resection of bladder tumor among patients taking antiplatelet agents for cardiovascular disease. ( Bozzini, G; Carmignani, L; Casellato, S; Marenghi, C; Picozzi, S; Ricci, C, 2014) |
| "The results of our meta-analysis suggest that there is no association between use of acetaminophen, aspirin or non-aspirin NSAIDs and bladder cancer risk." | 4.89 | Use of nonsteroidal anti-inflammatory drugs and bladder cancer risk: a meta-analysis of epidemiologic studies. ( Jiang, D; Li, X; Zhang, H, 2013) |
| "To determine the impact of fibrin clot inhibitor (FCI) use on oncological outcomes in a large contemporary cohort of patients with non-muscle-invasive bladder cancer (NMIBC) treated with adequate bacille Calmette-Guérin (BCG)." | 4.12 | Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Guérin? ( Bree, KK; Dinney, CP; Hensley, PJ; Kamat, AM; Lobo, N; Navai, N; Nogueras-Gonzalez, GM, 2022) |
| "The analysis of relevant databases will improve our mechanistic understanding of the role of aspirin in bladder cancer." | 4.12 | The targets of aspirin in bladder cancer: bioinformatics analysis. ( Gao, Y; Li, X; Liu, S; Tai, Y; Wang, X; Yin, J; Zhang, D; Zhang, DF; Zhang, H; Zhang, K, 2022) |
| "The aim of this study was to investigate the relation between bladder cancer risk and the use of selected drugs for cardiovascular disease (CVD) prevention, such as aspirin, statins, and calcium channel blockers (CCBs)." | 3.91 | Bladder cancer risk in users of selected drugs for cardiovascular disease prevention. ( Bosetti, C; Galfano, A; Guercio, V; La Vecchia, C; Libra, M; Montella, M; Polesel, J; Serraino, D; Tavani, A; Turati, F, 2019) |
| "This study aimed to evaluate the behavior of non-muscle-invasive bladder cancer (NMIBC) in patients submitted to transurethral bladder resection (TURB) comparing subjects in chronic therapy with aspirin, statins, or both drugs to untreated ones." | 3.81 | Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection. ( Al Salhi, Y; Carbone, A; Costantini, E; de Nunzio, C; Fuschi, A; Palleschi, G; Pastore, A; Petrozza, V; Silvestri, L; Zucchi, A, 2015) |
| "To determine if there is a difference in clinical outcomes among non-muscle-invasive bladder cancer patients taking fibrin clot-inhibiting (FCI) medications (aspirin, clopidogrel, or warfarin) while receiving Bacillus Calmette-Guérin (BCG) therapy compared with their counterparts not taking anticoagulation." | 3.79 | The effect of fibrin clot inhibitors on the immunomodulatory efficacy of Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer. ( Badalato, GM; Hruby, GW; Lipsky, MJ; McKiernan, JM; Motamedinia, P, 2013) |
| "Between September 2007 and April 2010, twelve patients receiving double antithrombotic therapy (clopidogrel+acetylsalicylic acid) underwent transurethral resection of bladder cancer." | 3.77 | Endoscopic resection of bladder cancer in patients receiving double platelet antiaggregant therapy. ( Arena, D; Bozzini, G; Carmignani, L; Casellato, S; Lunelli, L; Picozzi, S; Stubinski, R, 2011) |
| "To evaluate the recurrence-free survival (RFS) rate of patients taking cardioprotective aspirin after intravesical bacille Calmette-Guérin (BCG) for high-grade noninvasive urothelial carcinoma of the bladder, as preventing the recurrence of superficial bladder cancer might decrease patient morbidity and mortality from this disease, and nonsteroidal anti-inflammatory agents (NSAIDs) have shown promise in preclinical prevention through inhibition of the prostaglandin pathway and other mechanisms." | 3.75 | Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guérin. ( Bruskewitz, RC; Gee, JR; Hedican, SP; Jarrard, DF; Leverson, GE; Messing, EM; Moon, TD; Nakada, SY, 2009) |
| " However, acetaminophen, a major metabolite of phenacetin, may be positively associated with bladder cancer risk." | 3.74 | Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study. ( De Vivo, I; Genkinger, JM; Giovannucci, E; Michaud, DS; Stampfer, MJ, 2007) |
| " We investigated the activity of a recently developed NO-NSAID (NCX 4040) in bladder cancer cell lines (HT1376 and MCR)." | 3.73 | Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells. ( Amadori, D; Bolla, M; Bravaccini, S; Brigliadori, G; Fabbri, F; Rosetti, M; Tesei, A; Ulivi, P; Vannini, I; Zoli, W, 2005) |
| " There is substantial evidence that N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) is deformylated to 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in the process of FANFT-induced bladder cancer." | 3.67 | Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat. ( Cohen, SM; Davis, BB; Spry, LA; Zenser, TV, 1985) |
| "The authors investigated NSAID use and bladder cancer in 3 large prospective studies (NIH-AARP Diet and Health Study; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; and U." | 2.47 | Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis. ( Daugherty, SE; Hayes, RB; Hollenbeck, AR; Leitzmann, M; Pfeiffer, RM; Schatzkin, A; Sigurdson, AJ; Silverman, DT, 2011) |
| " The challenge for researchers and clinicians is to further understand which NSAIDs and what dosage and duration may provide the optimal benefit (if any), and to accurately construe the available current data on these agents for patients inquiring about these compounds." | 2.41 | An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II. ( Moyad, MA, 2001) |
| "Aspirin users were significantly older, more likely to have a history of cardiovascular disease and diabetes, and more likely to use metformin or statin (each p <0." | 1.48 | The Association of Aspirin Use with Survival Following Radical Cystectomy. ( Boorjian, SA; Cheville, JC; Frank, I; Karnes, RJ; Lyon, TD; Shah, PH; Tarrell, R; Thompson, RH; Tollefson, MK, 2018) |
| "Bladder cancer is a common urological malignancy with high recurrence rate, which may be reduced by chemoprevention." | 1.39 | Oral chemoprevention with acetyl salicylic Acid, vitamin D and calcium reduces the risk of tobacco carcinogen-induced bladder tumors in mice. ( Burcharth, J; Pommergaard, HC; Raskov, H; Rosenberg, J, 2013) |
| "Naproxen, which has an excellent cardiovascular profile, or epidermal growth factor receptor inhibitors may be effective in an adjuvant setting." | 1.36 | Screening agents for preventive efficacy in a bladder cancer model: study design, end points, and gefitinib and naproxen efficacy. ( Grubbs, CJ; Juliana, MM; Lubet, RA; Steele, VE, 2010) |
| "We analyzed data from 376 incident bladder cancer cases and 463 controls from a population-based case-control study in New Hampshire on whom regular use of analgesic drugs and NSAIDs was obtained." | 1.34 | Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study. ( Andrew, AS; Fortuny, J; Heaney, J; Karagas, MR; Kelsey, KT; Kogevinas, M; Schned, A; Zens, MS, 2007) |
| "Acute in-stent thrombosis is a well-known complication of carotid angioplasty and stenting (CAS) and often due to resistance to or inadequate treatment with platelet-inhibiting agents." | 1.33 | Late in-stent thrombosis following carotid angioplasty and stenting. ( Buhk, JH; Knauth, M; Wellmer, A, 2006) |
| "Aspirin is an inhibitor of prostaglandin H synthase and has been shown to inhibit FANFT-induced bladder carcinogenesis when coadministered in the diet." | 1.27 | Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats. ( Cohen, SM; Hasegawa, R; Johansson, SL; Sakata, T; Zenser, TV, 1986) |
| "aspirin were given daily." | 1.26 | Prostaglandin-mediated hypercalcemia in transitional cell carcinoma of the bladder. ( Gavrell, GJ; Kaplan, RA; Le Blanc, GA; McKay, HA; Meehan, WL, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (30.00) | 18.7374 |
| 1990's | 7 (14.00) | 18.2507 |
| 2000's | 11 (22.00) | 29.6817 |
| 2010's | 14 (28.00) | 24.3611 |
| 2020's | 3 (6.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albisinni, S | 1 |
| Diamand, R | 1 |
| Mjaess, G | 1 |
| Assenmacher, G | 1 |
| Assenmacher, C | 1 |
| Loos, S | 1 |
| Verhoest, G | 1 |
| Holz, S | 1 |
| Naudin, M | 1 |
| Ploussard, G | 1 |
| Mari, A | 1 |
| Di Maida, F | 1 |
| Minervini, A | 1 |
| Aoun, F | 1 |
| Tay, A | 1 |
| Issa, R | 1 |
| Roumiguié, M | 1 |
| Bajeot, AS | 1 |
| Simone, G | 1 |
| Anceschi, U | 1 |
| Umari, P | 1 |
| Sridhar, A | 1 |
| Kelly, J | 1 |
| Hendricksen, K | 1 |
| Einerhand, S | 1 |
| Sanchez-Salas, R | 1 |
| Colomer, A | 1 |
| Quackels, T | 1 |
| Peltier, A | 1 |
| Montorsi, F | 1 |
| Briganti, A | 1 |
| Pradere, B | 1 |
| Moschini, M | 1 |
| Roumeguère, T | 1 |
| Lobo, N | 1 |
| Hensley, PJ | 1 |
| Bree, KK | 1 |
| Nogueras-Gonzalez, GM | 1 |
| Navai, N | 1 |
| Dinney, CP | 1 |
| Kamat, AM | 1 |
| Li, X | 3 |
| Tai, Y | 1 |
| Liu, S | 1 |
| Gao, Y | 1 |
| Zhang, K | 1 |
| Yin, J | 1 |
| Zhang, H | 2 |
| Wang, X | 1 |
| Zhang, D | 1 |
| Zhang, DF | 1 |
| Prader, R | 1 |
| De Broca, B | 1 |
| Chevallier, D | 1 |
| Amiel, J | 1 |
| Durand, M | 1 |
| Guercio, V | 1 |
| Turati, F | 1 |
| Bosetti, C | 1 |
| Polesel, J | 1 |
| Serraino, D | 1 |
| Montella, M | 1 |
| Libra, M | 1 |
| Galfano, A | 1 |
| La Vecchia, C | 1 |
| Tavani, A | 1 |
| Lyon, TD | 1 |
| Frank, I | 1 |
| Shah, PH | 1 |
| Tarrell, R | 1 |
| Cheville, JC | 1 |
| Karnes, RJ | 1 |
| Thompson, RH | 1 |
| Tollefson, MK | 1 |
| Boorjian, SA | 2 |
| Wessels, F | 1 |
| Kriegmair, MC | 1 |
| Oehme, A | 1 |
| Rassweiler-Seyfried, MC | 1 |
| Erben, P | 1 |
| Oberneder, R | 1 |
| Kriegmair, M | 1 |
| Ritter, M | 1 |
| Michel, MS | 1 |
| Honeck, P | 1 |
| Lipsky, MJ | 1 |
| Badalato, GM | 1 |
| Motamedinia, P | 1 |
| Hruby, GW | 1 |
| McKiernan, JM | 1 |
| Jiang, D | 1 |
| Pommergaard, HC | 1 |
| Burcharth, J | 1 |
| Rosenberg, J | 1 |
| Raskov, H | 1 |
| Picozzi, S | 2 |
| Marenghi, C | 1 |
| Ricci, C | 1 |
| Bozzini, G | 2 |
| Casellato, S | 2 |
| Carmignani, L | 2 |
| Wada, N | 1 |
| Okazaki, S | 1 |
| Kobayashi, S | 1 |
| Hashizume, K | 1 |
| Hori, J | 1 |
| Azumi, M | 1 |
| Kita, M | 1 |
| Iwata, T | 1 |
| Matsumoto, S | 1 |
| Kakizaki, H | 1 |
| Pastore, A | 1 |
| Palleschi, G | 1 |
| Fuschi, A | 1 |
| Silvestri, L | 1 |
| Al Salhi, Y | 1 |
| Costantini, E | 1 |
| Zucchi, A | 1 |
| Petrozza, V | 1 |
| de Nunzio, C | 1 |
| Carbone, A | 1 |
| Singla, N | 1 |
| Haddad, AQ | 1 |
| Passoni, NM | 1 |
| Meissner, M | 1 |
| Lotan, Y | 1 |
| Gee, JR | 1 |
| Jarrard, DF | 1 |
| Bruskewitz, RC | 1 |
| Moon, TD | 1 |
| Hedican, SP | 1 |
| Leverson, GE | 1 |
| Nakada, SY | 1 |
| Messing, EM | 1 |
| Nguyen, TN | 1 |
| Berglund, RK | 1 |
| Maschino, AC | 1 |
| Savage, CJ | 1 |
| Herr, HW | 1 |
| Gonzalgo, ML | 1 |
| Lubet, RA | 1 |
| Steele, VE | 2 |
| Juliana, MM | 1 |
| Grubbs, CJ | 1 |
| Stubinski, R | 1 |
| Lunelli, L | 1 |
| Arena, D | 1 |
| Daugherty, SE | 1 |
| Pfeiffer, RM | 1 |
| Sigurdson, AJ | 1 |
| Hayes, RB | 1 |
| Leitzmann, M | 1 |
| Schatzkin, A | 1 |
| Hollenbeck, AR | 1 |
| Silverman, DT | 1 |
| Fabbri, F | 1 |
| Brigliadori, G | 1 |
| Ulivi, P | 1 |
| Tesei, A | 1 |
| Vannini, I | 1 |
| Rosetti, M | 1 |
| Bravaccini, S | 1 |
| Amadori, D | 1 |
| Bolla, M | 1 |
| Zoli, W | 1 |
| Buhk, JH | 1 |
| Wellmer, A | 1 |
| Knauth, M | 1 |
| Topakian, R | 1 |
| Nussbaumer, K | 1 |
| Trenkler, J | 1 |
| Aichner, FT | 1 |
| Genkinger, JM | 1 |
| De Vivo, I | 1 |
| Stampfer, MJ | 1 |
| Giovannucci, E | 1 |
| Michaud, DS | 1 |
| Ehrlich, Y | 1 |
| Yossepowitch, O | 1 |
| Margel, D | 1 |
| Lask, D | 1 |
| Livne, PM | 1 |
| Baniel, J | 1 |
| Fortuny, J | 1 |
| Kogevinas, M | 1 |
| Zens, MS | 1 |
| Schned, A | 1 |
| Andrew, AS | 1 |
| Heaney, J | 1 |
| Kelsey, KT | 1 |
| Karagas, MR | 1 |
| Bach, PH | 2 |
| Bridges, JW | 2 |
| Murasaki, G | 3 |
| Zenser, TV | 4 |
| Davis, BB | 3 |
| Cohen, SM | 6 |
| Hasegawa, R | 3 |
| St John, M | 1 |
| Fukushima, S | 2 |
| Mattammal, MB | 1 |
| Rapp, NS | 1 |
| Macklin, AW | 1 |
| Szot, RJ | 1 |
| P'ng, KB | 1 |
| Walsh, MD | 1 |
| Seymour, GJ | 1 |
| Lavin, MF | 1 |
| Gardiner, RA | 1 |
| Witjes, JA | 1 |
| vd Meijden, AP | 1 |
| Doesburg, W | 1 |
| Debruyne, FM | 1 |
| Klän, R | 1 |
| Knispel, HH | 1 |
| Meier, T | 1 |
| Rao, KV | 1 |
| Detrisac, CJ | 1 |
| Hawk, ET | 1 |
| Kelloff, GJ | 1 |
| McCormick, DL | 1 |
| Obrecht-Pflumio, S | 1 |
| Grosse, Y | 1 |
| Pfohl-Leszkowicz, A | 1 |
| Dirheimer, G | 1 |
| Günther, JH | 1 |
| Frambach, M | 1 |
| Deinert, I | 1 |
| Brandau, S | 1 |
| Jocham, D | 1 |
| Böhle, A | 1 |
| Moyad, MA | 1 |
| Handa, SP | 1 |
| McKay, HA | 1 |
| Gavrell, GJ | 1 |
| Meehan, WL | 1 |
| Kaplan, RA | 1 |
| Le Blanc, GA | 1 |
| Arger, PH | 1 |
| Bluth, EI | 1 |
| Murray, T | 1 |
| Goldberg, M | 1 |
| Nightingale, SL | 1 |
| Sakata, T | 2 |
| Johansson, SL | 2 |
| Popov, AI | 1 |
| Spry, LA | 1 |
| Silverstein, MJ | 1 |
| DeKernion, J | 1 |
| Morton, DL | 1 |
| Begley, M | 1 |
| Chadwick, JM | 1 |
| Jepson, RP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Must Aspirin be Discontinued Prior to TURBT: a Prospective, Randomized, Non-inferiority Trial Comparing Peri-operative Aspirin Continuation Versus Discontinuation.[NCT02350543] | Phase 4 | 50 participants (Actual) | Interventional | 2015-02-28 | Terminated (stopped due to Insufficient recruitment.) | ||
| To Investigate Post-procedure Hemorrhage and Cardiovascular Events in Taiwanese Patients Who Continue or Discontinue Low-Dose Aspirin Before Transrectal Prostate Biopsy: a Prospective Randomized Trial[NCT02744937] | Phase 4 | 150 participants (Anticipated) | Interventional | 2016-04-30 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for aspirin and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Use of nonsteroidal anti-inflammatory drugs and bladder cancer risk: a meta-analysis of epidemiologic studies.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Risk; Urinary Bladder Neopl | 2013 |
Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chi-Square Distribution; Female; Humans; Inc | 2011 |
An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxyge | 2001 |
Analgesic abuse nephropathy.
Topics: Analgesics; Aspirin; Calcinosis; Female; Humans; Kidney Failure, Chronic; Kidney Papillary Necrosis; | 1976 |
Chemically induced renal papillary necrosis and upper urothelial carcinoma. Part 1.
Topics: Acetaminophen; Aged; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Aspirin; Carbohy | 1985 |
3 trials available for aspirin and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Risks and complications of transurethral resection of bladder tumor among patients taking antiplatelet agents for cardiovascular disease.
Topics: Aged; Aspirin; Blood Transfusion; Cardiovascular Diseases; Female; Follow-Up Studies; Hemorrhage; Hu | 2014 |
Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial.
Topics: Aged; Aged, 80 and over; Aspirin; Cystoscopy; Drug Administration Schedule; Female; Fibrinolytic Age | 2007 |
Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial.
Topics: Aged; Aged, 80 and over; Aspirin; Cystoscopy; Drug Administration Schedule; Female; Fibrinolytic Age | 2007 |
Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial.
Topics: Aged; Aged, 80 and over; Aspirin; Cystoscopy; Drug Administration Schedule; Female; Fibrinolytic Age | 2007 |
Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial.
Topics: Aged; Aged, 80 and over; Aspirin; Cystoscopy; Drug Administration Schedule; Female; Fibrinolytic Age | 2007 |
From the Food and Drug Administration.
Topics: Acquired Immunodeficiency Syndrome; Aspirin; BCG Vaccine; Carcinoma in Situ; Clinical Trials as Topi | 1990 |
42 other studies available for aspirin and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort.
Topics: Aspirin; Cystectomy; Female; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complicati | 2022 |
Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Guérin?
Topics: Adjuvants, Immunologic; Administration, Intravesical; Anticoagulants; Aspirin; BCG Vaccine; Clopidog | 2022 |
The targets of aspirin in bladder cancer: bioinformatics analysis.
Topics: Aspirin; Computational Biology; Humans; Protein Interaction Maps; Urinary Bladder Neoplasms | 2022 |
Outcome of Transurethral Resection of Bladder Tumor: Does Antiplatelet Therapy Really Matter? Analysis of a Retrospective Series.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Carcinoma, Transitional Cell; Clopidogrel; C | 2017 |
Bladder cancer risk in users of selected drugs for cardiovascular disease prevention.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiotonic Agents | 2019 |
The Association of Aspirin Use with Survival Following Radical Cystectomy.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cystectomy; Disease-Free Survival; Female; F | 2018 |
Radical cystectomy under continuous antiplatelet therapy with acetylsalicylic acid.
Topics: Aged; Aspirin; Blood Loss, Surgical; Blood Transfusion; Cardiovascular Diseases; Case-Control Studie | 2019 |
The effect of fibrin clot inhibitors on the immunomodulatory efficacy of Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Anticoagulants; Aspirin; BCG Vaccine; Clopidogrel; | 2013 |
Oral chemoprevention with acetyl salicylic Acid, vitamin D and calcium reduces the risk of tobacco carcinogen-induced bladder tumors in mice.
Topics: Administration, Oral; Animals; Aspirin; Calcium; Calcium, Dietary; Carcinogens; Disease Models, Anim | 2013 |
[Perioperative complications of transurethral resection of bladder tumor in patients receiving antithrombotic therapy].
Topics: Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Cystectomy; Female; Fibrinolytic Agents; Hemorrha | 2014 |
Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection.
Topics: Aspirin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neoplasm | 2015 |
Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; Anti-Inflammatory Agents, Non-Steroidal; | 2017 |
Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guérin.
Topics: Administration, Intravesical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; | 2009 |
Aspirin-induced postoperative bleeding.
Topics: Aspirin; Emergencies; Humans; Male; Middle Aged; Nursing Assessment; Platelet Aggregation Inhibitors | 2009 |
Fibrin clot inhibitor medication and efficacy of bacillus Calmette-Guerin for bladder urothelial cancer.
Topics: Adjuvants, Immunologic; Aged; Anticoagulants; Aspirin; BCG Vaccine; Carcinoma, Transitional Cell; Cl | 2009 |
Editorial comment.
Topics: Adjuvants, Immunologic; Anticoagulants; Aspirin; BCG Vaccine; Carcinoma, Transitional Cell; Clopidog | 2009 |
Screening agents for preventive efficacy in a bladder cancer model: study design, end points, and gefitinib and naproxen efficacy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Cyclooxygenase Inh | 2010 |
Endoscopic resection of bladder cancer in patients receiving double platelet antiaggregant therapy.
Topics: Aged; Aged, 80 and over; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Coronary Restenosis; Fem | 2011 |
Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Aspirin; Cell Cycle; Cell | 2005 |
Late in-stent thrombosis following carotid angioplasty and stenting.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Angioplasty, Balloon; Anticoagulants; Aph | 2006 |
Late in-stent thrombosis following carotid angioplasty and stenting.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Angioplasty, Balloon; Anticoagulants; Aph | 2007 |
Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study.
Topics: Acetaminophen; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Follow | 2007 |
Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study.
Topics: Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Female; Hu | 2007 |
The role of metabolic activation of analgesics and non-steroidal anti-inflammatory drugs in the development of renal papillary necrosis and upper urothelial carcinoma.
Topics: Acetaminophen; Analgesics; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Aspirin; B | 1984 |
Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis.
Topics: Animals; Aspirin; FANFT; Male; Rats; Stomach Neoplasms; Thiazoles; Urinary Bladder Neoplasms | 1984 |
Effect of aspirin on N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced epithelial proliferation in the urinary bladder and forestomach of the rat.
Topics: Animals; Aspirin; Carcinogens; Cell Division; Epithelium; FANFT; Male; Rats; Rats, Inbred F344; Stom | 1984 |
Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
Topics: Animals; Aspirin; Biotransformation; Cyclooxygenase Inhibitors; FANFT; Hyperplasia; Male; Neoplasms, | 1981 |
Eighteen month oral study of aspirin, phenacetin and caffeine, in C57Bl/6 mice.
Topics: Animals; Aspirin; Caffeine; Carcinogens; Diet; Female; Kidney; Liver; Liver Neoplasms; Male; Mice; M | 1980 |
The adverse effect of fibrin-clot inhibiting drugs on intravesical bacillus Calmette-Guérin efficacy for superficial bladder cancer.
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroida | 1993 |
Influence of fibrin clot inhibitors on the efficacy of intravesical Bacillus Calmette-Guérin in the treatment of superficial bladder cancer. The Dutch Southeast Cooperative Urological Group.
Topics: Administration, Intravesical; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; BCG | 1993 |
Acetylsalicylic acid inhibition of n-butyl-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats.
Topics: Animals; Anticarcinogenic Agents; Aspirin; Butylhydroxybutylnitrosamine; Male; Rats; Rats, Wistar; U | 1993 |
Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Butylhydroxybuty | 1996 |
Protection by indomethacin and aspirin against genotoxicity of ochratoxin A, particularly in the urinary bladder and kidney.
Topics: Animals; Anticarcinogenic Agents; Aspirin; DNA Adducts; DNA Damage; Indomethacin; Kidney; Kidney Neo | 1996 |
Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49).
Topics: Adjuvants, Immunologic; Administration, Intravesical; Animals; Anti-Inflammatory Agents, Non-Steroid | 1999 |
Analgesic nephropathy and urothelial carcinoma.
Topics: Analgesics; Aspirin; Caffeine; Carcinoma, Transitional Cell; Codeine; Female; Humans; Kidney Neoplas | 1979 |
Prostaglandin-mediated hypercalcemia in transitional cell carcinoma of the bladder.
Topics: Animals; Aspirin; Calcium; Carcinoma, Transitional Cell; Chemical Phenomena; Chemistry; Female; Fibr | 1978 |
Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
Topics: Animals; Aspirin; FANFT; Kidney; Male; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344 | 1989 |
Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats.
Topics: Animals; Aspirin; Body Weight; Cocarcinogenesis; FANFT; Hydrogen-Ion Concentration; Male; Rats; Rats | 1986 |
[Effect of the nonspecific prevention of thrombogenic complications on late results in the combined treatment of bladder cancer].
Topics: Adult; Aged; Aspirin; Combined Modality Therapy; Female; Follow-Up Studies; Gamma Rays; Humans; Male | 1987 |
Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat.
Topics: Administration, Oral; Animals; Aspirin; Carcinoma; FANFT; Glomerular Filtration Rate; In Vitro Techn | 1985 |
Malignant melanoma metastatic to the bladder. Regression following intratumor injection of BCG vaccine.
Topics: Aspirin; BCG Vaccine; Biopsy; Cystoscopy; Diphenhydramine; Humans; Immunotherapy; Male; Melanoma; Mi | 1974 |
A possible case of analgesic abuse associated with transitional-cell carcinoma of the bladder.
Topics: Adult; Analgesics; Aspirin; Carcinoma, Transitional Cell; Humans; Urinary Bladder Neoplasms | 1970 |